VRS
PSTX

Virginia Retirement Systems’s Poseida Therapeutics, Inc. Common Stock PSTX Stock Holding History

Virginia Retirement Systems’s Portfolio PSTX Stock Details PSTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-34,900
Closed -$107K – 1131
2023
Q1 		$107K Buy
+34,900
New +$209K ﹤0.01% 1003

Other funds holding PSTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $980M AUM 470.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
ACM
Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return

Virginia Retirement Systems's PSTX Position: Q2 2023 in Review

Virginia Retirement Systems sold out of Poseida Therapeutics, Inc. Common Stock (PSTX) in Q2 2023, closing a stake of 34,900 shares — an estimated $107K sold.

Virginia Retirement Systems first reported a position in PSTX in Q1 2023 and held it in 1 quarter. The position peaked at $107K in Q1 2023. 94 funds tracked by Wall St. Rank hold PSTX as of Q2 2023.

  • Virginia Retirement Systems reported no remaining Poseida Therapeutics, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
  • Virginia Retirement Systems sold 34,900 Poseida Therapeutics, Inc. Common Stock shares in Q2 2023, an estimated $107K.
  • Virginia Retirement Systems first reported a position in Poseida Therapeutics, Inc. Common Stock in Q1 2023 and held it in 1 quarter.
  • Virginia Retirement Systems's Poseida Therapeutics, Inc. Common Stock position peaked at $107K in Q1 2023.
  • 94 funds tracked by Wall St. Rank held Poseida Therapeutics, Inc. Common Stock as of Q2 2023.

Based on Virginia Retirement Systems's 13F filing for Q2 2023, filed 22 Aug 2023.